VOLUNTARY ANNOUNCEMENT Launch of BRiSC, an siRNA Therapeutics Discovery Platform
Filed with HKEX · Stock code 2137 · · 2 pages · English
Summary by 6ix AI
Brii Biosciences Limited has announced the launch of BRiSC™, a proprietary siRNA therapeutics discovery platform. The platform aims to enhance the development of RNA-based therapies through advanced technologies. BRiSC™ integrates multiple technologies to improve the selectivity and performance of siRNA medicines. The company is expanding its research capabilities to support various internal discovery programs. Shareholders are cautioned about the uncertainties in the development and commercialization of the platform.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/voluntary-announcement-launch-of-brisc-an-sirna-therapeutics-discovery-platform
Brii Biosciences Limited on 6ix
Earlier from Brii Biosciences
- Next Day Disclosure Return
- Grant of share options and restricted share units
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Notification Letter and Request Form for Non-registered Shareholders
- Notification Letter and Change Request Form for Registered Shareholders
Follow Brii Biosciences into a list and get an email when it puts out news.
Follow Brii Biosciences